Oriental Aromatics
- P/E
- 355.88
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 4.47%
- Debt to Equity
- 0.61
- EPS (TTM)
- ₹1.59
- Book Value
- ₹197.46
- Market Cap
- —
- P/E (TTM)
- 355.88
- P/B
- 2.87
- ROE
- 0.50%
- Dividend Yield
- 0.09%
- EBITDA
- ₹77.60 Cr
- 52W High
- ₹645.00
- 52W Low
- ₹228.00
- Volume
- 0
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹565.85 | 355.88 | ₹1,870 Cr | 2.87 | 0.09% | 0.50% | 4.47% | ₹1,065 Cr | ₹5 Cr | |
| Median 8 companies | ₹1,559.55 | 57.54 | ₹20,474 Cr | 4.68 | 0.16% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 38
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 20
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 60
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 33
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 98
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 49
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 24.8%
Weaknesses
4- Stock is trading at 3.18 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.78% over past five years.
- Company has a low return on equity of 2.41% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 6 | 6 | 7 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bearish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 50.51
- Neutral
- MACD (12,26,9)
- 17.24
- Bearish
- SMA (50)
- 529.90
- Bullish
- SMA (200)
- 362.49
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | +7.78% |
|---|---|
| 3Y | +6.48% |
| 1Y | +11.10% |
| TTM | +13.54% |
Net profit
| 5Y | −50.60% |
|---|---|
| 3Y | −46.87% |
| 1Y | −91.18% |
| TTM | −77.68% |
Operating cash flow
| 5Y | −34.82% |
|---|---|
| 3Y | Turned positive |
| 1Y | Turned positive |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −15.40 pp |
|---|---|
| 3Y | +0.28 pp |
| 1Y | −3.53 pp |
| TTM | −2.88 pp |
Revenue by year
| Mar 2017 | ₹458 Cr |
|---|---|
| Mar 2018 | ₹506 Cr |
| Mar 2019 | ₹755 Cr |
| Mar 2020 | ₹760 Cr |
| Mar 2021 | ₹709 Cr |
| Mar 2022 | ₹873 Cr |
| Mar 2023 | ₹854 Cr |
| Mar 2024 | ₹842 Cr |
| Mar 2025 | ₹928 Cr |
| Mar 2026 | ₹1,031 Cr |
Net profit by year
| Mar 2017 | ₹28.00 Cr |
|---|---|
| Mar 2018 | ₹25.00 Cr |
| Mar 2019 | ₹57.00 Cr |
| Mar 2020 | ₹86.00 Cr |
| Mar 2021 | ₹102 Cr |
| Mar 2022 | ₹53.00 Cr |
| Mar 2023 | ₹20.00 Cr |
| Mar 2024 | ₹9.00 Cr |
| Mar 2025 | ₹34.00 Cr |
| Mar 2026 | ₹3.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 196 | 227 | 197 | 216 | 216 | 237 | 223 | 253 | 226 | 271 | 252 | 282 | 260 |
| Expenses | 195 | 216 | 183 | 196 | 194 | 208 | 200 | 234 | 207 | 254 | 238 | 263 | 240 |
| Operating Profit | 0.93 | 11.01 | 14.11 | 20.88 | 22.11 | 28.62 | 22.55 | 19.27 | 18.06 | 17.24 | 13.22 | 19.46 | 19.8 |
| OPM % | 0.48% | 4.85% | 7.15% | 9.65% | 10.25% | 12.09% | 10.13% | 7.61% | 8.01% | 6.35% | 5.26% | 6.89% | 7.62% |
| Other Income | 0.58 | 2.81 | 2.16 | 1.74 | 1.69 | 2.1 | 0.09 | 0.24 | 0.27 | 3 | 2.06 | 4.27 | 1 |
| Interest | 4.6 | 5.46 | 6.87 | 3.43 | 4.06 | 6.34 | 6.36 | 8.62 | 8.07 | 9.72 | 9.3 | 8.66 | 7.81 |
| Depreciation | 4.81 | 4.94 | 4.96 | 5.08 | 4.89 | 5.16 | 6.4 | 7.23 | 7.7 | 7.81 | 7.82 | 7.74 | 7.72 |
| PBT | −7.92 | 3.42 | 4.44 | 14.11 | 14.85 | 19.22 | 9.88 | 3.66 | 2.56 | 2.71 | −1.84 | 7.33 | 5.27 |
| Tax % | −23.64% | 29.24% | 41.22% | 28.28% | 26.13% | 23.1% | 27.73% | 60.93% | 80.47% | 73.06% | 4.35% | 45.7% | 52.37% |
| Net Profit | −6.05 | 2.42 | 2.61 | 10.12 | 10.98 | 14.78 | 7.14 | 1.42 | 0.5 | 0.74 | −1.92 | 3.99 | 2.51 |
| EPS (₹) | −1.8 | 0.72 | 0.78 | 3.01 | 3.26 | 4.39 | 2.12 | 0.42 | 0.15 | 0.22 | −0.57 | 1.19 | 0.75 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 458 | 506 | 755 | 760 | 709 | 873 | 854 | 842 | 928 | 1,031 | 1,065 |
| Expenses | 400 | 441 | 639 | 633 | 553 | 780 | 799 | 795 | 835 | 963 | 995 |
| Operating Profit | 57 | 65 | 116 | 127 | 156 | 93 | 54 | 47 | 94 | 68 | 70 |
| OPM % | 13% | 13% | 15% | 17% | 22% | 11% | 6% | 6% | 10% | 7% | 7% |
| Other Income | 6 | 0 | −2 | 7 | 1 | 4 | 6 | 7 | 3 | 10 | 10 |
| Interest | 5 | 7 | 13 | 12 | 2 | 4 | 13 | 20 | 25 | 36 | 35 |
| Depreciation | 14 | 15 | 18 | 19 | 17 | 17 | 19 | 20 | 24 | 31 | 31 |
| PBT | 44 | 43 | 83 | 103 | 137 | 76 | 27 | 14 | 48 | 11 | 13 |
| Tax % | 37% | 42% | 31% | 16% | 26% | 30% | 28% | 35% | 28% | 69% | — |
| Net Profit | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 3 | 5 |
| EPS (₹) | 13.54 | 7.43 | 16.98 | 25.61 | 30.29 | 15.84 | 5.87 | 2.7 | 10.2 | 0.98 | 1.59 |
| Div. Payout % | 3% | 7% | 6% | 10% | 8% | 9% | 9% | 18% | 5% | 51% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 311 | 329 | 375 | 447 | 540 | 588 | 608 | 616 | 646 | 648 |
| Borrowings | 105 | 132 | 183 | 51 | 78 | 140 | 231 | 206 | 353 | 403 |
| Other Liabilities | 69 | 103 | 98 | 93 | 110 | 120 | 130 | 157 | 129 | 127 |
| Total Liabilities | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 |
| Fixed Assets | 211 | 212 | 245 | 236 | 236 | 265 | 273 | 270 | 480 | 460 |
| CWIP | 15 | 40 | 1 | 2 | 13 | 25 | 53 | 173 | 5 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 264 | 321 | 428 | 370 | 496 | 574 | 661 | 551 | 660 | 730 |
| Total Assets | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1,145 | 1,194 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 16 | −23 | 181 | 17 | −1 | −22 | 142 | −34 | 2 |
| Investing | — | −31 | −12 | −10 | −35 | −59 | −46 | −99 | −86 | −12 |
| Financing | — | 15 | 36 | −159 | 16 | 51 | 78 | −48 | 121 | 12 |
| Net Cash Flow | — | 0 | 0 | 12 | −2 | −9 | 9 | −5 | 0 | 3 |
| Free Cash Flow | — | −15 | −36 | 171 | −18 | −60 | −69 | 43 | −121 | −9 |
| CFO/EBITDA | — | 51 | 0 | 162 | 36 | 23 | −23 | 309 | −20 | 11 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 97 | 77 | 73 | 97 | 81 | 81 | 78 | 74 | 89 |
| Inventory Days | 141 | 148 | 149 | 124 | 211 | 183 | 233 | 177 | 238 | 203 |
| Days Payable | 41 | 68 | 39 | 43 | 66 | 52 | 55 | 52 | 50 | 44 |
| Cash Conversion Cycle | 180 | 177 | 187 | 154 | 242 | 213 | 259 | 203 | 262 | 247 |
| Working Capital Days | 117 | 90 | 87 | 109 | 154 | 151 | 139 | 99 | 96 | 87 |
| ROCE % | — | 11% | 19% | 21% | 24% | 12% | 5% | 4% | 8% | 4% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Oriental Aromatics insights
63 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Jul 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Concall · Feb 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- 8 Aug 2025
- 23 Feb 2026
- 15 Oct 2025
- 15 Jul 2025
- 16 Jul 2024
- 8 Jun 2023
- General announcements 30 Oct 2026
- General announcements 29 Oct 2026
- General announcements 16 Oct 2026
Frequently Asked Questions about Oriental Aromatics
What does Oriental Aromatics Ltd do?
Where is Oriental Aromatics Ltd (OAL) listed?
Which sector does Oriental Aromatics Ltd belong to?
What is the PE ratio of Oriental Aromatics Ltd?
What is the 52-week high and low of Oriental Aromatics Ltd?
Does Oriental Aromatics Ltd pay dividends?
What is the Return on Equity (ROE) of Oriental Aromatics Ltd?
Company Information
Incorporated in 1973, Oriental Aromatics Ltd is a manufacturer of specialty-based aroma chemicals, camphor, and flavour and fragrance products
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/OAL.md for Oriental Aromatics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.